![]() |
![]() |
AbstractObjectivesThis study aimed to calculate the age-adjusted incidence rate of head and neck cancer (HNC) in South Korea from 1999 to 2020 and to analyze HNC incidence trends while excluding the effects of population aging.
MethodsData were obtained from the Cancer Registration Statistics Program. All 12 types of HNCs were analyzed. Crude incidence rates and the number of new cases from 1999 to 2020 were presented by sex and age group. Age-adjusted incidence rates were calculated using the World Standard Population (World Health Organization [WHO] 2000–2025), and trends were assessed.
ResultsAlthough the crude incidence rates of all HNCs increased steadily from 1999 to 2020, the absolute values remained low in most cases, at less than 2 per 100,000. The male-to-female ratio was 1 or higher for all HNCs except thyroid cancer, and 10 or higher for laryngeal and hypopharyngeal cancers. Age-adjusted incidence trends showed a gradual increase for tongue cancer, tonsil cancer, major salivary gland cancer, and thyroid cancer, a decrease for laryngeal cancer, and no significant change for the remaining HNCs.
INTRODUCTIONHead and neck cancer (HNC) encompasses a variety of subsites and ranks as the 7th most common cancer globally, with over 660,000 cases annually [1]. Smoking and alcohol consumption are well-established risk factors for HNC, though their impact varies by subsite. Human papillomavirus (HPV) infection is also a significant factor, particularly for oral and oropharyngeal cancers [1,2]. In South Korea, while HPV infection rates are rising, the incidence of HNC was expected to decline due to decreasing smoking rates, the strongest risk factor for HNC [1,3,4]. However, the incidence of HNC across all subsites has continued to rise since 1999, when statistics were first compiled [5]. This trend is partly explained by South Korea’s rapidly aging population [6].
Since the incidence of most chronic diseases, including cancer, increases with age, the overall cancer incidence in South Korea is naturally rising [6]. To evaluate cancer trends independent of population aging, age-adjusted incidence rates are essential [7]. Age-adjusted incidence is calculated by applying age-specific incidence rates from a population of interest to a standardized age distribution [7]. If the age-adjusted incidence of a cancer type increases or decreases over time, it is crucial to investigate the underlying causes. Recently, age-adjusted incidence has been increasingly used in studies of HNC in South Korea [8-10].
South Korea has a relatively large population of approximately 52 million, with all citizens enrolled in a single national health insurance system [11]. Cancer patients must register with the Korean Central Cancer Registry, managed by the National Health Insurance Service, to access various benefits. As a result, nearly all new cancer cases are recorded, enabling accurate HNC incidence data [8-10,12]. This robust system allows for precise calculation of age-adjusted incidence rates [7].
This study aimed to determine the population-based incidence and age-adjusted incidence of HNC in South Korea over the past 20 years. The findings will help estimate future medical demands and inform the development of new preventive measures.
MATERIALS AND METHODSThis study was not subject to institutional review board approval, as it used publicly available data that did not contain any personally identifiable information, and informed consent was therefore not required.
Cancer registration statistics programThe Korea Central Cancer Registry statistics program continuously and systematically collects and manages patient information to calculate and monitor cancer incidence in Korea [12]. All hospitals nationwide must register new cancer patients in this program, and the registration headquarters classify and organize patients based on the primary site of cancer using the International Classification of Diseases, Tenth Revision (ICD-10) codes. The program publishes new cancer cases and crude incidence rate by sex and age group each year (1999–2020) and is freely available. Table 1 summarizes the types and ICD-10 codes of the HNCs included in this study.
Statistical analysisFor each HNC subsite, we summarized the annual number of cases from 1999 to 2020 by sex and age group. Age groups were classified as 39 years or younger, 40–49 years, 50–59 years, 60–69 years, 70–79 years, and 80 years or older. The male-to-female ratio was determined as the number of all male patients/number of female patients from 1999 to 2020. To calculate age-adjusted incidence rates, we used the World Standard Population (WHO 2000–2025) provided by the World Health Organization (WHO) as the reference population. The age-adjusted incidence is essentially a weighted average of age-specific incidences. In this calculation, the weights correspond to the population ratio of each age group in the standard population. The formula used to derive the age-adjusted incidence is as follows:
Age-adjusted incidence=∑ (crude incidence at 5-year interval×population ratio at 5-year interval of reference population) [7,12]. To evaluate the trend of age-adjusted incidence from 1999 to 2020, we used a linear trendline provided by Microsoft Excel version 21 (Microsoft). A significant increase or decrease was defined as a change in slope of 0.01/100,000 per year or more. As this study used data from the entire population, no statistical inference was performed.
RESULTSThe ICD codes, crude incidence rates, sex ratios, and age-adjusted incidence trends for all 12 subtypes of HNC are presented in Table 1. Although the crude incidence rates of nearly all HNCs have steadily increased from 1999 to 2020, the absolute values remained low in most cases, at less than 2 per 100,000. The male-to-female ratio was 1 or higher for all HNCs except thyroid cancer, and 10 or higher for laryngeal and hypopharyngeal cancers. The age-adjusted incidence trend showed a gradual increase for tongue cancer, tonsil cancer, major salivary gland cancer, and thyroid cancer, a decrease for laryngeal cancer, and no significant change for the remaining HNCs.
Lip, tongue, and other oral cavity cancersThe annual incidence of lip cancer was fewer than 50 cases, with men being approximately 1.6 times more likely to develop it than women. No increasing trend was observed. Tongue cancer was reported in 307 cases in 1999, steadily rising to 937 cases in 2020. It occurred approximately twice as often in men as in women. In men, cases were predominantly concentrated between the ages of 50 and 69, while in women, they were evenly distributed across all age groups. The age-adjusted incidence trend showed a significant increase. The pattern of other oral cavity cancers (excluding lip and tongue cancers) was similar to that of tongue cancer. Detailed data are presented in Fig. 1 and the Supplementary Material 1.
Tonsil and other oropharyngeal cancersTonsil cancer was reported in 136 cases in 1999, with the incidence sharply increasing to 618 cases in 2020. It occurred approximately six times more often in men than in women. In men, cases were predominantly concentrated between the ages of 50 and 69, while in women, they were evenly distributed across all age groups. The age-adjusted incidence trend showed a significant increase. The number of oropharyngeal cancer cases (excluding tonsil cancer) was relatively small but steadily increasing. Very few cases were reported in women. Detailed data are presented in Fig. 2 and the Supplementary Material 1.
Laryngeal and hypopharyngeal cancersApproximately 1,100–1,200 cases of laryngeal cancer occurred annually, with no significant change in incidence over the past 20 years. However, the age-adjusted incidence trend showed a sharp decline. Hypopharyngeal cancer occurred in about one-third of the number of laryngeal cancer cases, but its incidence has gradually increased. Both cancer types were approximately 10 times more common in men than in women. Detailed data are presented in Fig. 3 and the Supplementary Material 1.
Other HNCsThe incidence of nasal cavity and paranasal sinus cancer has steadily increased, with more than 400 cases recorded annually in recent years. It occurred approximately 1.7 times more often in men than in women. In men, cases were predominantly concentrated between the ages of 50 and 69, while in women, they were evenly distributed across all age groups.
Interestingly, major salivary gland cancer cases increased rapidly in number, with no significant difference in the sex ratio. The age-adjusted incidence trend also showed an increase. Additionally, these cases often occurred at a relatively young age. The incidence of nasopharyngeal cancer did not change significantly. It was three times more common in men and most frequently diagnosed between the ages of 50 and 59. Finally, the incidence of thyroid cancer increased rapidly from 1999 to 2012, then decreased, and began to rise slightly again from 2015. It was four times more common in women and occurred more frequently at a younger age. Detailed data are presented in Fig. 4 and the Supplementary Material 1.
DISCUSSIONIn this study, we observed that the crude incidence rates of nearly all HNCs have steadily increased from 1999 to 2020. However, when examining age-adjusted incidence trends, only tongue cancer, tonsil cancer, major salivary gland cancer, and thyroid cancer showed a gradual increase, while laryngeal cancer decreased. No significant changes were observed in the remaining HNCs.
Smoking is the strongest risk factor for HNC, particularly for laryngeal cancer [1,2]. The exact timing of laryngeal cancer development after smoking initiation is difficult to determine, as it depends on factors such as the amount of smoking, the age at which smoking began, and genetic predisposition. However, considering that Koreans typically start smoking between their late teens and late 20s, and laryngeal cancer most frequently occurs in individuals in their 60s, the estimated average lag time is approximately 40 years [5]. In the first comprehensive survey conducted in Korea in 1980, smoking rates for men and women over 20 were 79.3% and 12.6%, respectively. By 1985, these rates had decreased to 71.2% for men and 7.8% for women [13]. According to the National Health and Nutrition Examination Survey in 1998, smoking rates were 66.3% for men and 6.5% for women, and they have continued to decline, reaching 30.0% for men and 5.0% for women in 2022 (Fig. 5A) [14]. As smoking rates have dramatically decreased since the early 1980s, the age-adjusted incidence rate of laryngeal cancer dropped by 54% from 1999 to 2020. Given the approximately 40-year lag time between smoking initiation and laryngeal cancer development, and the ongoing decline in smoking rates, the age-adjusted incidence of laryngeal cancer is expected to continue decreasing in the future. However, the impact of smoking appears limited for other HNCs, as their age-adjusted incidence did not decrease significantly.
Alcohol consumption also significantly influences the occurrence of HNCs and is known to have a synergistic effect when combined with smoking [1,2]. Drinking rates in Korea remain high. According to the National Health and Nutrition Assessment, in 2005, 73.3% of men and 36.2% of women aged 20 or older reported drinking alcohol, with no significant changes observed by 2022 (Fig. 5B) [14]. Therefore, the decline in the age-adjusted incidence of laryngeal cancer is likely primarily due to reduced smoking rates.
HPV is known to cause various cancers, including tonsil and base-of-tongue cancers among HNCs [1,8,15]. HPV-associated tonsil cancer, which often occurs in young individuals who do not smoke or drink alcohol, responds well to chemotherapy and radiation therapy [8,15]. Although epidemiological studies on HPV infection rates in South Korea are limited, the infection rate is believed to be high and increasing (Fig. 5C) [3]. In this study, the age-adjusted incidence of tonsil cancer showed a significant increase. Given the decline in smoking rates and stable drinking rates, the rise in HPV infection is presumed to be a key factor driving the increase in tonsil cancer. Additionally, while most HNCs predominantly affect individuals in their 60s and 70s, tonsil cancer occurs most frequently in those in their 50s. This pattern suggests that HPV infection plays a significant role in tonsil cancer development. Nationwide education efforts to reduce HPV infection through vaccination and safe sex practices are needed to prevent tonsil cancer. Fortunately, the increasing trend of tonsil cancer cases among individuals aged 40–59 in Korea has slowed since 2008 [8].
The age-adjusted incidence of tongue cancer also increased significantly. While tongue cancer is strongly influenced by smoking, it is minimally affected by HPV, unlike oropharyngeal cancers such as tonsil cancer [1,2]. Logically, tongue cancer incidence was expected to decrease in the context of declining smoking rates and rising HPV infection rates. We propose three potential hypotheses to explain this phenomenon. First, cases of tongue base cancer may have been misclassified as oral tongue cancer, particularly in advanced stages where distinguishing the primary site is challenging. Second, HPV may directly influence the development of oral tongue cancer. Third, a global trend of increasing tongue cancer incidence among younger individuals may also be occurring in Korea [8]. Nevertheless, the underlying causes of this trend remain unclear.
Another notable finding is the rapid increase in major salivary gland cancer incidence from 1999 to 2020. Similar trends have been observed in Japan and the United States [16,17], although not in other countries [9]. Unlike other HNCs, major salivary gland cancer is not strongly associated with smoking or alcohol consumption [1,2]. Potential causes include occupational exposure to carcinogens, radiation, diet, family history, and viral infections [1,2]. However, the exact reason for this increase remains unknown [9]. Additionally, major salivary gland cancer occurs evenly across all age groups and has a similar sex ratio, which is unique compared to other HNCs that predominantly affect men over 60. This distinction may be due to the fact that most HNCs are squamous cell carcinomas, whereas major salivary gland cancer comprises 10 different types originating from various parts of the salivary gland [1,2,16,17].
The incidence of thyroid cancer in Korea has risen rapidly since the 2000s [10,18]. This increase may be attributed to high iodine intake, a high prevalence of the BRAF gene mutation, and a high frequency of chronic thyroiditis among Koreans. However, the primary driver is the increased diagnosis rate due to the widespread use of thyroid ultrasound examinations [18]. The incidence rate declined sharply around 2013 as public opposition to thyroid ultrasound screenings grew and treatment practices evolved. However, it has gradually increased again since 2015. According to a study by Kang et al. [10], which analyzed thyroid cancer staging in Koreans, advanced cases (T3 and T4) accounted for 47.1%, suggesting that this increase is not solely due to overdiagnosis.
The primary limitation of this study is the inability to precisely assess the individual impact of specific risk factors on HNC development. This limitation stems from the lack of detailed data on each patient’s exposure to known risk factors, such as smoking, alcohol consumption, and HPV infection. Therefore, the study could not determine the distinct contribution of each factor to HNC occurrence. Future research should address this gap by incorporating comprehensive exposure data to enable a more nuanced understanding of the relationship between these risk factors and HNC.
In conclusion, the incidence of all HNCs in Korea has steadily increased over the past 20 years. However, the age-adjusted incidence trend showed a gradual increase only for tongue cancer, tonsil cancer, major salivary gland cancer, and thyroid cancer. Laryngeal cancer incidence decreased, while no significant changes were observed in the remaining HNCs. A thorough analysis is needed to understand the factors driving the increase in cancers with rising age-adjusted incidence.
HIGHLIGHTS▪ In Korea, the incidence of all head and neck cancers has steadily increased over the past 20 years.
▪ However, the age-adjusted incidence trend has shown a gradual increase only for tongue cancer, tonsil cancer, major salivary gland cancer, and thyroid cancer, whereas the incidence of laryngeal cancer has decreased.
▪ The rise in tonsil cancer is attributed to increased human papillomavirus infection rates, and the decline in laryngeal cancer is likely due to reduced smoking rates.
CONFLICTS OF INTERESTACKNOWLEDGMENTS This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2021R1A2C2004382 to YCL). AUTHOR CONTRIBUTIONS Conceptualization: JHC, YCL. Methodology: JDS. Software: JHC. Validation: JDS. Formal analysis: JHC. Investigation: JHC. Resources: JHC, YCL. Data curation: JHC. Visualization: JHC. Supervision: JDS. Project administration: JHC. Funding acquisition: YCL. Writing–original draft: JHC, YCL. Writing–review & editing: JDS. All authors read and agreed to the published version of the manuscript. SUPPLEMENTARY MATERIALSSupplementary materials can be found online at https://doi.org/10.21053/ceo.2024.00346.
Fig. 1.Number of new cases, age distribution, and age-adjusted incidence rate (per 100,000) of oral cavity cancers from 1999 to 2000. (A) Lip cancer, (B) tongue cancer, (C) other oral cavity cancer, and (D) unspecified oral cavity cancer. The dotted line indicates a trendline. Fig. 2.Number of new cases, age distributions, and age-adjusted incidence rate (per 100,000) of oropharyngeal cancers from 1999 to 2000. (A) Tonsil cancer. (B) Other oropharyngeal cancer. The dotted line indicates a trendline. Fig. 3.Number of new cases, age distributions, and age-adjusted incidence rate (per 100,000) of laryngeal and hypopharyngeal cancers from 1999 to 2000. (A) Laryngeal cancer. (B) Hypopharyngeal cancer. The dotted line indicates a trendline. Fig. 4.Number of new cases, age distributions, and age-adjusted incidence rate (per 100,000) of other head and neck cancers from 1999 to 2000. (A) Nasal cavity or paranasal sinus cancer. (B) Major salivary gland cancer. (C) Nasopharyngeal cancer. (D) Thyroid cancer. The dotted line indicates a trendline. Fig. 5.Trends in the smoking rate, drinking rate, and human papillomavirus infection rate in South Korea. (A) Smoking rate (data from the National Health and Nutrition Assessment [14]). (B) Drinking rate (data from the National Health and Nutrition Assessment [14]). (C) Number of patients who developed disease due to papillomavirus infection (data from Health Insurance Review and Assessment Service Bigdata Open Portal [3]). Table 1.Types of head and neck cancers included in this study REFERENCES1. Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022 Nov;233(9):780-6.
2. Cohen N, Fedewa S, Chen AY. Epidemiology and demographics of the head and neck cancer population. Oral Maxillofac Surg Clin North Am. 2018 Nov;30(4):381-95.
3. Health Insurance Review and Assessment Service (HIRA) Bigdata Open Portal. Number of patients who developed disease due to papillomavirus infection [Internet]. HIRA; 2024 [cited 2025 Jan 30]. Available from: https://opendata.hira.or.kr/op/opc/olap4thDsInfoTab1.do.
4. Yeob KE, Kim SY, Kim YY, Park JH. Nationwide prevalence and trends in cigarette smoking among adult men with and without disabilities in South Korea between 2009 and 2017. Public Health. 2023 Sep;222:92-9.
5. Suh JD, Cho JH. Trends in head and neck cancer in South Korea between 1999 and 2012. Clin Exp Otorhinolaryngol. 2016 Sep;9(3):263-9.
6. Hyun KR, Kang S, Lee S. Population aging and healthcare expenditure in Korea. Health Econ. 2016 Oct;25(10):1239-51.
7. National Cancer Institute, National Institutes of Health. Calculating age-adjusted rates from “Surveillance, epidemiology, and end results program” [Internet]. National Cancer Institute; 2024 [cited 2025 Jan 30]. Available from: https://seer.cancer.gov/seerstat/tutorials/aarates/step1.html.
8. Jung YS, Seok J, Hong S, Ryu CH, Ryu J, Jung KW. The emergence of oral cavity cancer and the stabilization of oropharyngeal cancer: recent contrasting epidemics in the South Korean population. Cancer. 2021 May;127(10):1638-47.
9. Seok J, Park EH, Jung KW, Chang JW. Recent trends in the incidence of salivary gland malignancies. Korean J Head Neck Oncol. 2022 Nov;38(2):1-5.
10. Kang YJ, Choi N, Seok J, Kim SW, Kim TH, Chung JH, et al. Changing trends of thyroid cancer clinical characteristics and treatment pattern in South Korea: insights from an institutional database and the Korean cancer center registry database. Int J Thyroidol. 2024 Nov;17(2):277-85.
11. Shin Y, Lee L. The health insurance system in Korea and its implications. World Hosp Health Serv. 1995;31(3):3-9.
12. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011 Mar;43(1):1-11.
13. Song TM. Changes in smoking rates of male adults in Korea and smoking cessation policy: focus on smoking cessation clinics. Health Welf Forum. 2011 Mar;(173):55-63.
14. Health Insurance Review and Assessment Service (HIRA) Bigdata Open Portal. Data from the National Health and Nutrition Assessment [Internet]. HIRA; 2024 [cited 2025 Jan 30]. Available from: https://opendata.hira.or.kr/op/opc/olap4thDsInfoTab3.do.
15. Nasman A, Du J, Dalianis T. A global epidemic increase of an HPV-induced tonsil and tongue base cancer: potential benefit from a pangender use of HPV vaccine. J Intern Med. 2020 Feb;287(2):134-52.
16. Del Signore AG, Megwalu UC. The rising incidence of major salivary gland cancer in the United States. Ear Nose Throat J. 2017 Mar;96(3):E13-6.
|
|
||||||||||||||||||||||||||||||||||||||||||||||

![]() |
![]() |